Elite Pharmaceuticals GAAP EPS of $0.01, revenue of $31.6M
Source: SeekingAlpha
2026-02-17 16:34:00 ET
More on Elite Pharmaceuticals
- Seeking Alpha’s Quant Rating on Elite Pharmaceuticals
- Financial information for Elite Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Elite Pharmaceuticals GAAP EPS of $0.01, revenue of $31.6M
Elite Pharmaceuticals Inc.
NASDAQ: ELTP
ELTP Trading
-2.37% G/L:
$0.387 Last:
227,483 Volume:
$0.399 Open:
ELTP Latest News
February 17, 2026 04:19:00 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
February 11, 2026 04:30:00 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
ELTP Stock Data
$453,759,839
743,518,083
0.33%
2
757074%
Pharmaceuticals
Healthcare
US
Northvale
